NEW CORONAVIRUS INFECTION (COVID-19) IN 2022: CLINICAL AND EPIDEMIOLOGICAL FEATURES
Abstract
Over the period of the new coronavirus infection (COVID-19) pandemic from 2020 to 2022, 411939 cases of the disease were registered in the Chelyabinsk region. In the 2022 season, the structure of the clinical forms of COVID-19 was changed.
Objective of the research: to analyze the current features of the course of COVID-19. Material and methods. A retrospective analysis of the case histories of patients with COVID-19 who were hospitalized at the «Regional Infectious Diseases Center» GAUZ OKB №3 of the Ministry of Health of the Chelyabinsk Region in 2022 was carried out. The diagnosis was verified using polymerase chain reaction (PCR).
Results and discussion. There were two periods of an increase in the incidence of COVID-19: in January-February and in Au- gust-September 2022. 10041 people were hospitalized, in the first 48-72 hours of the disease 32% of patients consulted a doctor, the average age of the hospitalized was 72±5.2 years. At the onset of the disease, patients complained of abdominal pain in 26.3±3.9% of cases, nausea/vomiting in 29.1±4.9% and diarrhea in 32.5±4.1% of cases. The severity of lung damage according to computed tomography CT 0 was recorded more often than CT 1 and CT 2. Mortality among hospitalized patients amounted to 10.5%.
About the Authors
L. V. Ter-Bagdasaryan
ФГБОУ ВО «Южно-Уральский государственный медицинский университет» Минздрава России
Russian Federation
Russian Federation
L. I. Ratnikova
ФГБОУ ВО «Южно-Уральский государственный медицинский университет» Минздрава России
Russian Federation
Russian Federation
References
1. Gosudarstvennyj doklad «O sostojanii sanitarno-jepidemiologicheskogo blagopoluchija naselenija v Cheljabinskoj oblasti v 2022 godu» («On the state of sanitary and epidemiological welfare of the population in the Chelyabinsk region in 2022») podgotovlen Upravleniem Rospotrebnadzora po Cheljabinskoj oblasti i FBUZ «Centr gigieny i jepidemiologii v Cheljabinskoj oblasti», 2023 – 239 s. [Jelektronnyj resurs] URL: https://74.rospotrebnadzor.ru/c/document_library/get_file?uuid=0d242301-40a8-40a5-8ee1-fcbe587ae1a8&groupId=10156 (data obrashhenija 01.05.2023) (in Russ)
2. Vremennye metodicheskie rekomendacii «Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19)» («Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19)») versija 17 ot 14.12.2022. [Jelektronnyj resurs]. URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/061/254/original/VMR_COVID-19_V17.pdf?1671088207(data obrashhenija 01.05.2023)
3. Effenberger M., Grabherr F., Mayr L., [et al.] Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020; 69 (8): 1543-1544. (in Engl). DOI: 10.1136/gutjnl-2020-321388.
4. Bezzio C., Saibeni S., Variola A. [et al.] Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. 2020;69(7):1213–1217. (in Engl). DOI: 10.1136/gutjnl-2020-321411.
5. Megyeri K., Dernovics Á., Al-Luhaibi Z. I. I., Rosztóczy A. COVID-19-associated diarrhea. World J Gastroenterol. 2021; 27(23): 3208-3222. (in Engl). DOI: 10.3748/wjg.v27.i23.3208.
6. Simon D., Tascilar K., Krönke G. [et al.] Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nat Commun. 2020;11(1):3774. (in Engl). DOI: 10.1038/s41467-020-17703-6.
7. Ivashkin V.T., Zolnikova O.Yu., Okhlobystin A.V. and others. New coronavirus infection (COVID-19) and the digestive system. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(2):7 (In Russ). DOI: 10.22416/1382-4376-2020-30-3-7
8. Xiao F., Tang M., Zheng X. [et al.] Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–1833.e3. (in English). DOI: 10.1053/j.gastro.2020.02.055.
9. Mandal S., Barnett J., Brill S. E. [et al.] ARC Study Group. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021; 76 (4): 396-398. DOI: 10.1136/thoraxjnl-2020-215818.
10. Shkurko T. V., Veselov A. V., Knyazev O. V. [i dr.] Osobennosti novoi koronavirusnoi infektsii COVID-19 u patsientov s zabolevaniyami zheludochno-kishechnogo trakta (Features of the new COVID-19 coronavirus infection in patients with diseases of the gastrointestinal tract). Vremennye metodicheskie rekomendatsii № 69. Moskva: GBU «NIIOZMM DZM», 2020:32. (In Russ).
Review
For citations:
Ter-Bagdasaryan L.V., Ratnikova L.I. NEW CORONAVIRUS INFECTION (COVID-19) IN 2022: CLINICAL AND EPIDEMIOLOGICAL FEATURES. Bashkortostan Medical Journal. 2023;18(3):14-18. (In Russ.)
Views:
42
Email this article 
